Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment-Reference-Cited by-同舟云学术

Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment

Published:2000-12 Issue:6 Volume:32 Page:1386-1395
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Berg Thomas,Marques Andreas Mas,Höhne Marina,Wiedenmann Bertram,Hopf Uwe,Schreier Eckart

Publisher

Wiley

Subject

Hepatology

Reference36 articles.

1. Randomized trial of interferon α2b plus ribavirin for 48 weeks or 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus;Poynard;Lancet,1998

2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C;McHutchison;N Engl J Med,1998

3. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b;Enomoto;J Clin Invest,1995

4. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C;Enomoto;N Engl J Med,1996

5. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection;Chayama;Hepatology,1997

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of New E2 Protein Domain Interaction with PKR Protein to Control IFN Signaling;Current Proteomics;2021-10-15

2. The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response;Scientific Reports;2017-11-14

3. Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method;Clinical Laboratory;2017

4. Frequency of nucleotide sequence variations in the internal ribosome entry site region of hepatitis C virus RNA isolated from responding and non-responding patients with hepatitis C virus genotype 3 infection;VirusDisease;2016-08-06

5. The role of HCV proteins on treatment outcomes;Virology Journal;2015-12